Effective complex formation in the interaction of 1,2-dimethyl-3-hydroxypyrid-4-one (Deferiprone or L1) with uranium(VI)

被引:0
|
作者
I. Pashalidis
G. J. Kontoghiorghes
机构
[1] University of Cyprus,Department of Natural Sciences
[2] Postgraduate Research Institute of Science,undefined
[3] Technology,undefined
[4] Environment and Medicine,undefined
来源
Journal of Radioanalytical and Nuclear Chemistry | 1999年 / 242卷
关键词
Uranium; Normal Condition; Complex Formation; Extinction Coefficient; Stability Constant;
D O I
暂无
中图分类号
学科分类号
摘要
In an effort to develop new chelating agents for the decorporation of uranium and other actinides, the interaction of the clinically used 1,2-dimethyl-3-hydroxypyrid-4-one (Deferiprone or L1) with hexavalent uranium was investigated by using UV-VIS spectroscopy and solubility measurements. The complex stoichiometry estimation carried out by the Job plot method indicated that under normal conditions up to pH 8.0 a 1[U(VI)]∶1[L1] complex is formed. The stability constant of the UO2L1+ complex was determined by spectroscopic and solubility experiments and found to be log β11=9.1±0.3. The molar extinction coefficient at pH 7.6 for the complex at 500 nm was estimated to be 650 l·mol−1·cm−1. At ligand concentrations higher than 6·10−4 mol·l−1 the formation of a precipitate was observed. The stoichiometry UO2(L1)2 was identified following FTIR measurements of the red precipitate and UV/VIS spectroscopy after dissolution.
引用
收藏
页码:181 / 184
页数:3
相关论文
共 50 条
  • [1] Effective complex formation in the interaction of 1,2-dimethyl-3-hydroxypyrid-4-one (Deferiprone or L1) with uranium(VI)
    Pashalidis, I
    Kontoghiorghes, GJ
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 1999, 242 (01) : 181 - 184
  • [2] Effective complex formation in the interaction of 1,2-dimethyl-3- hydroxypyrid-4-one (Deferiprone or L1) with uranium(VI)
    Department of Natural Sciences, University of Cyprus, P.O. Box 537, Cy-1678 Nicosia, Cyprus
    J. Radioanal. Nucl. Chem., 1 (181-184):
  • [3] EFFECTS OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) ON CELL-PROLIFERATION
    ELORRIAGA, R
    FRAGA, PM
    NAVES, ML
    CANNATA, JB
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 587 - 587
  • [4] Interaction between 1,2-dimethyl-3-hydroxypyrid-4-one and europium(III)
    P. Hadjiloizou
    I. Pashalidis
    Journal of Radioanalytical and Nuclear Chemistry, 2007, 273 : 553 - 556
  • [5] Interaction between 1,2-dimethyl-3-hydroxypyrid-4-one and europium(III)
    Hadjiloizou, P.
    Pashalidis, I.
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2007, 273 (03) : 553 - 556
  • [6] LONG-TERM TRIAL WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1)
    KONTOGHIORGHES, GJ
    BARTLETT, AN
    HOFFBRAND, AV
    GODDARD, JG
    SHEPPARD, L
    BARR, J
    NORTEY, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 295 - 300
  • [8] 4-WEEK ORAL TOXICITY STUDY OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN UREMIC RATS
    GOMEZ, M
    DOMINGO, JL
    DELCASTILLO, D
    LLOBET, JM
    CORBELLA, J
    VETERINARY AND HUMAN TOXICOLOGY, 1995, 37 (04) : 346 - 348
  • [9] USE OF THE NEW ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN THALASSEMIA PATIENTS
    MATSUI, D
    OLIVIERI, N
    KOREN, G
    TEMPLETON, D
    LIU, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 144 - 144
  • [10] ORAL IRON CHELATION WITH 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN IRON-LOADED THALASSEMIA PATIENTS
    OLIVIERI, NF
    MATSUI, D
    LIU, PP
    BLENDIS, L
    CAMERON, R
    MCCLELLAND, RA
    TEMPLETON, DM
    KOREN, G
    BONE MARROW TRANSPLANTATION, 1993, 12 : 9 - 11